Stockscreener 앱 받기
271.63
1.72%
4.58
시간 외 거래:
271.63
Resmed Inc 주식(RMD)의 최신 뉴스
Insider Sell: Peter Farrell Sells 2,000 Shares of ResMed Inc (RM - GuruFocus
Insider Sell: Michael Rider Sells Shares of ResMed Inc (RMD) - GuruFocus
Resmed: global general counsel Rider sells $13,000 in stock - Investing.com
Resmed director Farrell sells $502k in stock By Investing.com - Investing.com India
ResMed (NYSE:RMD) General Counsel Sells $13,000.00 in Stock - MarketBeat
ResMed (NYSE:RMD) Director Sells $502,620.00 in Stock - MarketBeat
Smart Sand, Inc. Achieves 140.93% Return, Outperforming NetApp and ResMed - Markets Mojo
RMD Stock Up Following Q2 Earnings & Revenue Beat, Margins Expand - TradingView
ResMed Chief Legal Officer Sells 50 Common Shares Of Firm - marketscreener.com
ResMed Director Sells 2,000 Shares - marketscreener.com
Why Brambles, HMC Capital, ResMed, and Rio Tinto shares are rising today - The Motley Fool Australia
ResMed Inc (RMD) Stock Price Down 0% on Feb 5 - GuruFocus
The Top 5 Analyst Questions From ResMed’s Q4 Earnings Call - The Globe and Mail
The Top 5 Analyst Questions From ResMed's Q4 Earnings Call - Finviz
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD) Gets a Buy from UBS - The Globe and Mail
ResMed Deepens CPAP Lead As Wearables And Digital Tools Expand Reach - Yahoo Finance
ResMed Adjusts CDI and Share Balances Amid Ongoing Capital Management - TipRanks
What can investors expect from ResMed, Cochlear and CSL shares this reporting season? - The Motley Fool Australia
Allianz Asset Management GmbH Acquires 110,647 Shares of ResMed Inc. $RMD - MarketBeat
WCM Investment Management LLC Makes New Investment in ResMed Inc. $RMD - MarketBeat
ResMed Slipped 1% on Profit Beat: Is $400 the 2026 Recovery Target? - TIKR.com
The Truth About ResMed Inc.: Why Everyone Is Suddenly Paying Attention - AD HOC NEWS
ResMed At Wearable And AI Turning Point In Sleep Apnea Care - Sahm
Insider Sell Alert: Brett Sandercock Sells Shares of ResMed Inc (RMD) - GuruFocus
ResMed CFO Sells 1,000 Shares Under Pre-Set Trading Plan - TipRanks
ChartWatch ASX Scans: Appen, Aussie Broadband, Flight Centre Travel, Resmed, Siteminder, Sunrise Energy Metals - Market Index
Resmed Founder Receives 2026 Horatio Alger Award - respiratory-therapy.com
Zacks Industry Outlook Highlights Boston Scientific, ResMed, Phibro Animal Health and BioLife Solutions - Yahoo Finance
Sleep device maker ResMed ramps up doctor outreach to tap Ozempic surge - Yahoo Finance
ResMed Inc. (RMD): A Bull Case Theory - Finviz
Ord Minnett Sticks to Its Buy Rating for Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD) - The Globe and Mail
ResMed Inc. (RMD) Stock Analysis: A Strong Performer With 15% Upside Potential - DirectorsTalk Interviews
ResMed (RMD) Rating Maintained by Citigroup as Price Target Rises | RMD Stock News - GuruFocus
ResMed Bull Anticipates Further Buybacks -- Market Talk - 富途牛牛
National Pension Service Grows Stake in ResMed Inc. $RMD - MarketBeat
ResMed Inc. $RMD Shares Bought by Mediolanum International Funds Ltd - MarketBeat
Morgans Financial Upgrades ResMed to Buy from Accumulate, Price Target is AU$47.73 - marketscreener.com
Assessing ResMed (RMD) Valuation After Strong Fiscal Q2 Earnings Beat And AI Product Momentum - Sahm
Portfolio Shifts: How volatile is ResMed Inc stock2025 Top Gainers & Expert-Curated Trade Recommendations - baoquankhu1.vn
ResMed outlines 62%–63% gross margin target for fiscal 2026 amid double-digit growth in key segments - MSN
ResMed Inc Earnings Call Shows Profitable Growth Momentum - TipRanks
ResMed Bull Stays Positive Amid Strong Revenue Growth -- Market Talk - 富途牛牛
ResMed: Interim result 2026 - intelligentinvestor.com.au
ResMed Files Quarterly Form 10-Q for December 2025 - TipRanks
ResMed Inc. $RMD Shares Acquired by Keybank National Association OH - MarketBeat
ResMed: Facing A Potentially Dream-Disrupting DoseStrong Sell - Seeking Alpha
ResMed (RMD) Net Margin Strength In Q2 2026 Supports Bullish Earnings Narrative - Sahm
Analysts Offer Insights on Healthcare Companies: Stryker (SYK), NewAmsterdam Pharma Company (NAMS) and Resmed (RMD) - The Globe and Mail
ResMed Reaffirms 2025 Risk Profile: No Material Changes to Previously Disclosed Threats - TipRanks
Is Federal Agricultural Mortgage Corporation stock trending bullishGap Down & Technical Pattern Based Buy Signals - baoquankhu1.vn
RMD Q4 Deep Dive: Mask Innovation and Digital Health Expansion Drive Growth - Finviz
KeyBanc raises ResMed stock price target to $302 on solid revenue beat - Investing.com UK
Breaking Down ResMed: 7 Analysts Share Their Views - Benzinga
ResMed’s Profitability Surge Driven by Operational Excellence - AD HOC NEWS
Explore ResMed Market Coverage and Healthcare Sector Context - Kalkine Media
Analysts Maintain Bull Case On ResMed Despite Competition Concerns - Benzinga
Resmed posts Street-beating Q2 results amid increased CPAP demand - MassDevice
Resmed Q2: Mask sales surge as new products, resupply gain traction | - HME News
ResMed stock price target raised to $314 from $311 at RBC Capital By Investing.com - Investing.com South Africa
Wells Fargo & Company Forecasts Strong Price Appreciation for ResMed (NYSE:RMD) Stock - MarketBeat
Wells Fargo Analyst Raises ResMed (RMD) Price Target to $270 | R - GuruFocus
ResMed Inc. (NYSE:RMD) Declares Quarterly Dividend of $0.60 - MarketBeat
ResMed stock price target raised to $314 from $311 at RBC Capital - Investing.com Nigeria
2.38%
자본화:
|
볼륨(24시간):